{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T09:04:32Z","timestamp":1774343072374,"version":"3.50.1"},"reference-count":31,"publisher":"Japanese Society of Internal Medicine","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2023,10,15]]},"DOI":"10.2169\/internalmedicine.1788-23","type":"journal-article","created":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T22:11:18Z","timestamp":1689718278000},"page":"3063-3067","source":"Crossref","is-referenced-by-count":5,"title":["Nonepisodic Angioedema with Eosinophilia Following Receipt of the BNT162b2 mRNA COVID-19 Vaccine"],"prefix":"10.2169","volume":"62","author":[{"given":"Tamaki","family":"Koda","sequence":"first","affiliation":[{"name":"Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bunki","family":"Natsumoto","sequence":"additional","affiliation":[{"name":"Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Shoda","sequence":"additional","affiliation":[{"name":"Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keishi","family":"Fujio","sequence":"additional","affiliation":[{"name":"Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Baden LR, El Sahly HM, Essink B, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med 384: 403-416, 2021.","DOI":"10.1056\/NEJMoa2035389"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med 383: 2603-2615, 2020.","DOI":"10.1056\/NEJMoa2034577"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Bozkurt B, Kamat I, Hotez PJ. Myocarditis with COVID-19 mRNA vaccines. Circulation 144: 471-484, 2021.","DOI":"10.1161\/CIRCULATIONAHA.121.056135"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Izuka S, Komai T, Natsumoto B, Shoda H, Fujio K. Self-limited polymyalgia rheumatica-like syndrome following mRNA-1273 SARS-CoV-2 vaccination. Intern Med 61: 903-906, 2022.","DOI":"10.2169\/internalmedicine.8829-21"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Furer V, Eviatar T, Zisman D, et al. Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study. Ann Rheum Dis 80: 1330-1338, 2021.","DOI":"10.1136\/annrheumdis-2021-220647"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Kounis NG, Mplani V, Koniari I, Velissaris D. Hypersensitivity myocarditis and COVID-19 vaccines. Kardiol Pol 80: 109-110, 2022.","DOI":"10.33963\/KP.a2021.0166"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Takeda M, Ishio N, Shoji T, Mori N, Matsumoto M, Shikama N. Eosinophilic myocarditis following coronavirus disease 2019 (COVID-19) vaccination. Circ J 86: 1020, 2022.","DOI":"10.1253\/circj.CJ-21-0935"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Ando M, Satonaga Y, Takaki R, et al. Acute asthma exacerbation due to the SARS-CoV-2 vaccine (Pfizer-BioNTech BNT162b2 messenger RNA COVID-19 vaccine [Comirnaty<sup>\u00ae<\/sup>]). Int J Infect Dis 124: 187-189, 2022.","DOI":"10.1016\/j.ijid.2022.09.019"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Ozturk AB, \u00c7a\u011flayan B, Kapmaz M, et al. Hypersensitivity reactions to COVID-19 vaccines: a case of Eosinophilic pneumonia following Sinovac\/CoronaVac vaccination. Eur Ann Allergy Clin Immunol 55: 41-45, 2023.","DOI":"10.23822\/EurAnnACI.1764-1489.247"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Barrio Piqueras M, Ezponda A, Felgueroso C, et al. Acute eosinophilic pneumonia following mRNA COVID-19 vaccination: a case report. Arch Bronconeumol 58: 53-54, 2022.","DOI":"10.1016\/j.arbres.2021.11.004"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Miqdadi A, Herrag M. Acute eosinophilic pneumonia associated with the anti-COVID-19 vaccine AZD1222. Cureus 13: e18959, 2021.","DOI":"10.7759\/cureus.18959"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Ibrahim H, Alkhatib A, Meysami A. Eosinophilic granulomatosis with polyangiitis diagnosed in an elderly female after the second dose of mRNA vaccine against COVID-19. Cureus 14: e21176, 2022.","DOI":"10.7759\/cureus.21176"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Ikediobi O, Eichenfield DZ, Barrio VR. Eosinophilic cellulitis in response to BNT162b2 COVID-19 vaccination. Pediatr Dermatol 39: 823-824, 2022.","DOI":"10.1111\/pde.15019"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. de Montjoye L, Marot L, Baeck M. Eosinophilic cellulitis after BNT162b2 mRNA Covid-19 vaccine. J Eur Acad Dermatol Venereol 36: e26-e28, 2022.","DOI":"10.1111\/jdv.17685"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Kaikati J, Ghanem A, El Bahtimi R, Helou J, Tomb R. Eosinophilic panniculitis: a new side effect of Sinopharm COVID-19 vaccine. J Eur Acad Dermatol Venereol 36: e337-e339, 2022.","DOI":"10.1111\/jdv.17920"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Lee JY, Lee JH. mRNA COVID-19 vaccine-associated subserosal eosinophilic gastroenteritis: a case report. J Korean Med Sci 37: e233, 2022.","DOI":"10.3346\/jkms.2022.37.e233"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Gleich GJ, Schroeter AL, Marcoux JP, Sachs MI, O&apos;Connell EJ, Kohler PF. Episodic angioedema associated with eosinophilia. N Engl J Med 310: 1621-1626, 1984.","DOI":"10.1056\/NEJM198406213102501"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18. Chikama R, Hosokawa M, Miyazawa T, Miura R, Suzuki T, Tagami H. Nonepisodic angioedema associated with eosinophilia: report of 4 cases and review of 33 young female patients reported in Japan. Dermatology 197: 321-325, 1998.","DOI":"10.1159\/000018025"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Nakachi S, Inokuma S. Eleven cases of angioedema with eosinophilia treated in a single hospital in Japan. Allergol Int 61: 259-263, 2012.","DOI":"10.2332\/allergolint.11-OA-0351"},{"key":"20","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1182\/blood.V79.3.688.688","volume":"79","author":"JH Butterfield","year":"1992","unstructured":"20. Butterfield JH, Leiferman KM, Abrams J, et al. Elevated serum levels of interleukin-5 in patients with the syndrome of episodic angioedema and eosinophilia. Blood 79: 688-692, 1992.","journal-title":"Blood","ISSN":"https:\/\/id.crossref.org\/issn\/0006-4971","issn-type":"print"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Rosenberg HF, Foster PS. Eosinophils and COVID-19: diagnosis, prognosis, and vaccination strategies. Semin Immunopathol 43: 383-392, 2021.","DOI":"10.1007\/s00281-021-00850-3"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Lindsley AW, Schwartz JT, Rothenberg ME. Eosinophil responses during COVID-19 infections and coronavirus vaccination. J Allergy Clin Immunol 146: 1-7, 2020.","DOI":"10.1016\/j.jaci.2020.04.021"},{"key":"23","doi-asserted-by":"publisher","unstructured":"23. Sahin U, Muik A, Derhovanessian E, et al. COVID-19 vaccine BNT162b1 elicits human antibody and T<sub>H<\/sub>1 T cell responses. Nature 586: 594-599, 2020.","DOI":"10.1038\/s41586-020-2814-7"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Mizukawa Y, Shiohara T. The cytokine profile in a transient variant of angioedema with eosinophilia. Br J Dermatol 144: 169-174, 2001.","DOI":"10.1046\/j.1365-2133.2001.03969.x"},{"key":"25","doi-asserted-by":"publisher","unstructured":"25. Okamoto H, Kamatani N. Plasma concentration of TARC\/CCL17 is elevated in nonepisodic angioedema associated with eosinophilia. Allergy 60: 1091-1092, 2005.","DOI":"10.1111\/j.1398-9995.2005.00847.x"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Uesugi-Uchida S, Fujisaki M, Sekine S, Takenao C, Oyama N, Hasegawa M. Non-episodic angioedema with eosinophilia developing after influenza vaccination: a case report. J Dermatol 50: e96-e97, 2023.","DOI":"10.1111\/1346-8138.16626"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Hayashi R, Shimomura N, Hosojima M, Sakai A, Shigehara Y, Abe R. A case of non-episodic angioedema with eosinophilia induced by influenza vaccine. Eur J Dermatol 27: 554-555, 2017.","DOI":"10.1684\/ejd.2017.3123"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Ishizuka K, Katayama K, Kaji Y, Tawara J, Ohira Y. Non-episodic angioedema with eosinophilia after BNT162b2 mRNA COVID-19 vaccination. QJM 114: 745-746, 2021.","DOI":"10.1093\/qjmed\/hcab245"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Sato Y, Murata K, Kasami S, Kato M. Post-COMIRNATY<sup>\u00ae<\/sup> non-episodic angioedema with eosinophilia: an elderly case. Intern Med 61: 1927-1928, 2021.","DOI":"10.2169\/internalmedicine.8599-21"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Nam YH. Nonepisodic angioedema with eosinophilia after COVID-19 vaccination: a case successfully treated with reslizumab. Allergy Asthma Clin Immunol 19: 11, 2023.","DOI":"10.1186\/s13223-023-00765-8"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Harada T, Kosaka S, Nakai M. Non-episodic angioedema associated with eosinophilia after COVID-19. Eur J Case Rep Intern Med 9: 003671, 2022.","DOI":"10.12890\/2022_003671"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/20\/62_1788-23\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T03:26:01Z","timestamp":1697858761000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/20\/62_1788-23\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,15]]},"references-count":31,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.1788-23","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,15]]},"article-number":"1788-23"}}